Abstract:Objective: Investigation of the effect of endothelin receptor A (ETaR)-targeting small interfering RNA (siRNA) on rat vascular endothelial cellular hypoxia injury, as well as its underlying mechanism. Methods: An in vitro rat vascular smooth muscle cells - endothelial cells co-culture model was established and transfected with ETaR siRNA before hypoxia treatment. Cell culture supernatant, cellular protein and RNA were collected and examined at 0.5hrs, 1hrs, 2hrs, 4hrs, 8hrs, 16hrs, 24hrs and 48hrs of hypoxia with 1% oxygen. The time point at which the best silencing effect was achieved was chosen, eNOS inhibitor L-NAME was added, and post hypoxia cell culture supernatant, cellular protein and RNA was collected for further examination. Results: After hypoxic treatment, endothelial-1 (ET-1) and ETaR expression levels gradually increased as oxygen deprivation extended. ET-1 and ETaR expression levels were significantly lower in the ETaR siRNA group compared with the Hypoxia group (P<0.001). Such difference peaked at 4hrs of hypoxia. ELISA examination of cell culture supernatant revealed that the amount of ET-1 and TGF-βin the ETaR siRNA group were significantly lower compared to the Hypoxia group at all times, while the amount of NO and eNOS was higher. After 4 hrs of hypoxia, Smad2, Smad3, HIF-1, TNF-α, IFN-γ, IL-6, MCP-1, NF-κb, ET-1 and ANG II mRNA expression in endothelial cells and ETaR mRNA expression in A-10 cells of the ETaR siRNA group were lower than those of the Hypoxia siRNA group, while such results were much higher in the L-NAME group. Western Blot results showed lower expression of ETaR in the ETaR siRNA group compared with the hypoxia and negative siRNA groups, as well as significantly higher ETaR expression in the L-NAME group compared with the ETaR siRNA group. PI3K and p-AKT expression levels were mildly elevated after mild oxygen deprivation, and ETaR siRNA was able to enhance such elevation induced by hypoxia. In the L-NAME group, PI3K and p-AKT expression was much higher than the ETaR siRNA group. PKG and sGC expression levels significantly descended after mild oxygen deprivation. While such levels were higher in the ETaR siRNA group, compared with the hypoxia and negative siRNA groups, the L-NAME group had lower levels of PKG and sGC compared with the ETaR siRNA group. Conclusion: ETaR siRNA is capable of down-regulating the expression of inflammatory and transcription factors among endothelial cells treated with hypoxia. Down-regulation of ET-1 is triggered by altered nucleus transcription factor activity through the sGC/PKG signal pathway, and results in enhanced eNOS activity through the PI3K/Akt signal pathway. We suspect this to be the mechanism of the protective effect of ETaR siRNA.

Endothelin Receptor Down-Regulation Mediated Ligand Regulation Mechanisms Protect Against Cellular Hypoxia Injury in Rat Vascular Endothelial Cells

Downregulation of Endothelin A Receptor (etar) Ameliorates Renal Ischemia Reperfusion Injury by Increasing Nitric Oxide Production

Hypoxia-induced Reactive Oxygen Species Downregulate ETBreceptor-mediated Contraction of Rat Pulmonary Arteries

[Inhibitory Effect of Sirna Targeting HIF-1alpha on Differentiation of Peripheral Blood Endothelial Progenitor Cells].

Prevention of renal ischemia-reperfusion injury by short hairpin RNA of endothelin A receptor in a rat model.

Resveratrol Down-Regulates Endothelin Type B Receptors in Vascular Smooth Muscle Cells Via Sirt1/ERK1/2/NF-кB Signaling Pathways

[Endothelin-1 Overexpression Inhibits Rat Pulmonary Arterial Microvascular Smooth Muscle Cell Apoptosis Via Akt/PKB Pathway].

Reactive Oxygen Species Mediate Oxidized Low-Density Lipoprotein-Induced Endothelin-1 Gene Expression Via Extracellular Signal-Regulated Kinase in Vascular Endothelial Cells

Protective Effect of ETaR Sirna on Renal Ischemia-Reperfusion Injury in Rats by Changing the Immuno-Microenvironment of Kidney

Angiotensin-converting enzyme inhibitors provide a protective effect on hypoxia-induced injury in human coronary artery endothelial cells via Nrf2 signaling and PLVAP

Endothelial S1pr2 regulates post-ischemic angiogenesis via AKT/eNOS signaling pathway

Regulation of HIF-1α Expression by Small Interfering RNA Targeting HIF-1αin Human Vascular Endothelial Cells

Preventive Effect of Endothelin-1 Pretreatment on Hypoxia-Induced Injury in Cultured Neonatal Rat Cardiomyocytes

A8324 Suppression of Endothelial to Mesenchymal Transition by SIRT3 Alleviated the Development of Hypertensive Renal Injury

Effects of HIF-1α Sirna Interference on Expressions of HIF-1α and VEGF in Rat CBRH-7919 Hepatoma Cells

MicroRNA-27a/b Mediates Endothelin-1-induced PPARγ Reduction and Proliferation of Pulmonary Artery Smooth Muscle Cells

Antagonism of endothelin-1 inhibits hypoxia-induced apoptosis in cardiomyocytes.

Knockdown of Nrf2 inhibits angiogenesis by down-regulating VEGF expression through PI3K/Akt signaling pathway in cerebral microvascular endothelial cells under hypoxic conditions.

The Protective Effect of Tongxinluo to Endothelium Injured by Angiotensin-Ii in Vivo in Rats

Pre-B-Cell Colony Enhancing Factor (pbef) Increases Endothelial Permeability in Hypoxia/Re-Oxygenation Model

Minimally Modified LDL Upregulates Endothelin Type B Receptors in Rat Coronary Artery Via ERK1/2 MAPK and NF-κB Pathways